De Laere Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
De Laere Pharma
Largest movements
- Tangible fixed assets +€35,982
up €35,982 (+1,240%), from €2,901 to €38,883
- Cash +€23,733
up €23,733 (+280%), from €8,464 to €32,197
mainly Debts after one year (+€26,513) and Net result for the year (+€14,118)
- Receivables within one year -€11,117
down €11,117 (-51.8%), from €21,444 to €10,328
of which Trade receivables: -€10,084
- Current investments +€3,067
up €3,067 (+33.9%), from €9,041 to €12,108
- Debts after one year +€26,513
new in 2025: €26,513
- Reserves +€14,000
up €14,000 (+59.6%), from €23,500 to €37,500
- Current portion of long-term debt +€7,605
new in 2025: €7,605
- Other debts +€2,652
up €2,652 (+26.4%), from €10,063 to €12,715
- Trade debts +€1,004
up €1,004 (+168%), from €599 to €1,603
- Gross operating margin +€11,024
up €11,024 (+57.6%), from €19,153 to €30,178
- Depreciation +€7,397
up €7,397 (+1,656%), from €447 to €7,844
- Financial charges +€1,365
up €1,365 (+191%), from €714 to €2,079
- Taxes +€1,067
up €1,067 (+26.6%), from €4,004 to €5,071
- Other operating charges +€440
up €440 (+61.0%), from €722 to €1,162
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €42,629 | €94,125 | +€51,497 | +121% |
| Fixed assets | 21/28 | €3,201 | €39,183 | +€35,982 | +1,124% |
| Tangible fixed assets | 22/27 | €2,901 | €38,883 | +€35,982 | +1,240% |
| Furniture and vehicles | 24 | €2,901 | €38,883 | +€35,982 | +1,240% |
| Financial fixed assets | 28 | €300 | €300 | = | 0.0% |
| Current assets | 29/58 | €39,427 | €54,942 | +€15,515 | +39.4% |
| Amounts receivable within one year | 40/41 | €21,444 | €10,328 | -€11,117 | -51.8% |
| Trade receivables | 40 | €19,439 | €9,355 | -€10,084 | -51.9% |
| Other amounts receivable | 41 | €2,006 | €972 | -€1,033 | -51.5% |
| Current investments | 50/53 | €9,041 | €12,108 | +€3,067 | +33.9% |
| Cash at bank and in hand | 54/58 | €8,464 | €32,197 | +€23,733 | +280% |
| Deferred charges and accrued income | 490/1 | €478 | €310 | -€168 | -35.2% |
| Total equity and liabilities | 10/49 | €42,629 | €94,125 | +€51,497 | +121% |
| Equity | 10/15 | €26,293 | €40,411 | +€14,118 | +53.7% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Reserves | 13 | €23,500 | €37,500 | +€14,000 | +59.6% |
| Distributable reserves | 133 | €23,500 | €37,500 | +€14,000 | +59.6% |
| Profit (loss) carried forward | 14 | €293 | €411 | +€118 | +40.3% |
| Amounts payable | 17/49 | €16,335 | €53,714 | +€37,378 | +229% |
| Amounts payable after more than one year | 17 | - | €26,513 | +€26,513 | |
| Financial debts | 170/4 | - | €26,513 | +€26,513 | |
| Amounts payable within one year | 42/48 | €16,335 | €26,921 | +€10,586 | +64.8% |
| Current portion of amounts payable after more than one year | 42 | - | €7,605 | +€7,605 | |
| Trade debts | 44 | €599 | €1,603 | +€1,004 | +168% |
| Suppliers | 440/4 | €599 | €1,603 | +€1,004 | +168% |
| Taxes, remuneration and social security | 45 | €5,673 | €4,998 | -€675 | -11.9% |
| Taxes | 450/3 | €5,673 | €4,998 | -€675 | -11.9% |
| Other amounts payable | 47/48 | €10,063 | €12,715 | +€2,652 | +26.4% |
| Accrued charges and deferred income | 492/3 | - | €279 | +€279 | |
| Non-recurring operating income | 76A | - | €1,855 | +€1,855 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €447 | €7,844 | +€7,397 | +1,656% |
| Other operating charges | 640/8 | €722 | €1,162 | +€440 | +61.0% |
| Gross operating margin | 9900 | €19,153 | €30,178 | +€11,024 | +57.6% |
| Operating profit (loss) | 9901 | €17,985 | €21,171 | +€3,187 | +17.7% |
| Financial income | 75/76B | €31 | €96 | +€65 | +210% |
| Recurring financial income | 75 | €31 | €96 | +€65 | +210% |
| Financial charges | 65/66B | €714 | €2,079 | +€1,365 | +191% |
| Recurring financial charges | 65 | €714 | €2,079 | +€1,365 | +191% |
| Profit (loss) for the period before taxes | 9903 | €17,302 | €19,189 | +€1,887 | +10.9% |
| Income taxes | 67/77 | €4,004 | €5,071 | +€1,067 | +26.6% |
| Profit (loss) for the period | 9904 | €13,298 | €14,118 | +€820 | +6.2% |
| Profit (loss) for the period to be appropriated | 9905 | €13,298 | €14,118 | +€820 | +6.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.